Dr. Cerniglia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1441 Eastlake Ave
Los Angeles, CA 90033- Is this information wrong?
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Hematology and Medical Oncology, 2023 - 2026
Saint Joseph HospitalResidency, Internal Medicine, 2019 - 2022
Georgetown University School of MedicineClass of 2019
Certifications & Licensure
CA State Medical License 2023 - 2025
CO State Medical License 2021 - 2025
Publications & Presentations
PubMed
- Response to PD-1 inhibitor after progression on PD-L1 inhibitor in advanced HCC.Michael Cerniglia, Michal Klepadlo, David Sheneman, Sunnie S Kim> ;BMJ Case Reports. 2022 Aug 12
- 2 citationsTreatment of Metastatic Disease with Immune Checkpoint Inhibitors Nivolumab and Pembrolizumab: Effect of Performance Status on Clinical Outcomes.Leah Wells, Michael Cerniglia, Sarah Hall, Audrey C Jost, Gregory Britt> ;Journal of Immunotherapy and Precision Oncology. 2022 May 1
- 2 citationsAssociation of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers.Michael Cerniglia, Joanne Xiu, Axel Grothey, Michael J. Pishvaian, Yasmine Baca, Jimmy J. Hwang, John L. Marshall, Ari M. Vanderwalde, Anthony F. Shields, Heinz-Josef ...> ;Molecular Cancer Therapeutics. 2021 Nov 1
- Join now to see all
Hospital Affiliations
USC Norris Comprehensive Cancer CenterLos Angeles, California
Los Angeles General Medical CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
